Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

STLNSTLN
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in Starling Oncology, Inc.

GOLDMAN SACHS GROUP INC holds 1.7M shares of STLN (Starling Oncology, Inc.), worth $9.4M as of 2026-Q2. The position was increased (+28.4% shares). STLN represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$9.4M

Current Shares

1.7M

Total Value Change

+$9.3M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+28.4%
$9.4M0.0%$5.43
35
2026-Q1
Increased
1.4M
+137.0%
$4.2M0.0%$3.07
43
2025-Q4
Decreased
570,424
-16.3%
$2M0.0%$3.56
0
2025-Q3
Increased
681,643
+340.8%
$2.4M0.0%$3.49
42
2025-Q2
Increased
154,632
+34.3%
$316,9960.0%$2.05
21
2025-Q1
New
115,140
-
$131,2600.0%$1.14
34

Other major holders of STLN: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used